We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$38B
AUM Growth
+$2.83B
Cap. Flow
-$66.8M
Cap. Flow %
-0.18%
Top 10 Hldgs %
19.42%
Holding
2,424
New
34
Increased
1,207
Reduced
842
Closed
77

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$58.2M
2
EXC icon
Exelon
EXC
+$44.1M
3
PLD icon
Prologis
PLD
+$37.8M
4
JNJ icon
Johnson & Johnson
JNJ
+$29.9M
5
CI icon
Cigna
CI
+$28.6M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$63.9M
2
ALL icon
Allstate
ALL
+$39.3M
3
GILD icon
Gilead Sciences
GILD
+$31.8M
4
ENB icon
Enbridge
ENB
+$30.1M
5
ORCL icon
Oracle
ORCL
+$29.9M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 15.34%
3 Financials 13.83%
4 Consumer Discretionary 10.82%
5 Industrials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZEK
1951
DELISTED
The AZEK Co
AZEK
$123K ﹤0.01%
6,037
-15,507
-72% -$287K
LGF.B
1952
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$123K ﹤0.01%
22,569
+8,129
+56% +$53.9K
OLP
1953
One Liberty Properties
OLP
$512M
$122K ﹤0.01%
5,433
+342
+7% +$7.83K
OTTR icon
1954
Otter Tail
OTTR
$3.88B
$121K ﹤0.01%
2,054
PI icon
1955
Impinj
PI
$5.39B
$121K ﹤0.01%
1,104
PTON icon
1956
Peloton Interactive
PTON
$2.42B
$121K ﹤0.01%
15,157
LOVE
1957
LoveSac
LOVE
$253M
$120K ﹤0.01%
5,417
+2,335
+76% +$52.2K
PFC
1958
DELISTED
Premier Financial Corp. Common Stock
PFC
$120K ﹤0.01%
4,465
+1,577
+55% +$44.1K
AXSM icon
1959
Axsome Therapeutics
AXSM
$11.4B
$119K ﹤0.01%
1,541
FOCS
1960
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$119K ﹤0.01%
3,176
BCRX icon
1961
BioCryst Pharmaceuticals
BCRX
$2.51B
$117K ﹤0.01%
10,121
+1,284
+15% +$16K
SYBT icon
1962
Stock Yards Bancorp
SYBT
$2.58B
$117K ﹤0.01%
1,785
+351
+24% +$25.1K
PRMW
1963
DELISTED
Primo Water Corporation
PRMW
$117K ﹤0.01%
7,546
SNDR icon
1964
Schneider National
SNDR
$6.18B
$116K ﹤0.01%
4,932
-4,538
-48% -$106K
MVIS icon
1965
Microvision
MVIS
$86.9M
$114K ﹤0.01%
3,213
+1,224
+62% +$56.9K
PAGP icon
1966
Plains GP Holdings
PAGP
$4.98B
$113K ﹤0.01%
9,022
NHC icon
1967
National Healthcare
NHC
$3.46B
$112K ﹤0.01%
1,886
+758
+67% +$46K
LBRT icon
1968
Liberty Energy
LBRT
$3.45B
$111K ﹤0.01%
6,903
TAC icon
1969
TransAlta
TAC
$3.88B
$111K ﹤0.01%
12,317
-3,244
-21% -$29.1K
VNOM icon
1970
Viper Energy
VNOM
$15.3B
$111K ﹤0.01%
3,479
UVSP icon
1971
Univest Financial
UVSP
$1.16B
$109K ﹤0.01%
4,196
+1,539
+58% +$41.3K
ACB
1972
Aurora Cannabis
ACB
$179M
$107K ﹤0.01%
11,613
+5,545
+91% +$66.1K
FRPH icon
1973
FRP Holdings
FRPH
$415M
$107K ﹤0.01%
3,946
+304
+8% +$8.67K
HTBK
1974
DELISTED
Heritage Commerce
HTBK
$107K ﹤0.01%
8,265
+2,185
+36% +$29.4K
PEBO icon
1975
Peoples Bancorp
PEBO
$1.46B
$107K ﹤0.01%
3,780
+1,436
+61% +$42.2K

Similar funds

Canada Life's Q4 2022 Portfolio in Review

As of Q4 2022, Canada Life held 2,424 positions worth $38B, up 8% from $35.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.6%. Canada Life opened 34 new positions and exited 77, leaving the 2,424-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Canada Life's largest Q4 2022 buy was Stellantis: 4,179,449 shares worth $59.5M.
  • Canada Life added most to Exelon in Q4 2022, an estimated $44.1M increase.
  • Canada Life's biggest Q4 2022 reduction was Texas Instruments, cutting an estimated $63.9M.
  • Canada Life fully exited Brookfield in Q4 2022, selling an estimated $27.1M.
  • Canada Life's ten largest holdings make up 19% of its $38B portfolio in Q4 2022.
  • Canada Life opened 34 new positions and closed 77 in Q4 2022.
  • Canada Life's portfolio value rose 8% quarter-over-quarter to $38B.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.